This page shows the latest RVT-602 news and features for those working in and with pharma, biotech and healthcare.
Myovant has also received an exclusive, commercial license for RVT-602, Takeda's oligopeptide kisspeptin receptor agonist for the treatment of female infertility.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...